AG
CALA

Advisor Group’s Calithera Biosciences, Inc CALA Stock Holding History

Advisor Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
40
– – ﹤0.01% 4803
2019
Q3 		$2K Hold
40
– – ﹤0.01% 5033
2019
Q2 		$4K Hold
40
– – ﹤0.01% 4806
2019
Q1 		$6K Hold
40
– – ﹤0.01% 4625
2018
Q4 		$4K Hold
40
– – ﹤0.01% 4654
2018
Q3 		$4K Buy
+40
New +$3.81K ﹤0.01% 4697

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Advisor Group's CALA Position: Q4 2019 in Review

Advisor Group held its Calithera Biosciences, Inc (CALA) position steady in Q4 2019 at 40 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4803.

Advisor Group first reported a position in CALA in Q3 2018 and has held it in 6 quarters since. The position peaked at $6K in Q1 2019. 82 funds tracked by Wall St. Rank hold CALA as of Q4 2019.

  • Advisor Group held 40 shares of Calithera Biosciences, Inc worth $4K as of Q4 2019.
  • Advisor Group left its Calithera Biosciences, Inc share count unchanged in Q4 2019.
  • Calithera Biosciences, Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4803 holding.
  • Advisor Group first reported a position in Calithera Biosciences, Inc in Q3 2018 and has held it in 6 quarters since.
  • Advisor Group's Calithera Biosciences, Inc position peaked at $6K in Q1 2019.
  • 82 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.